Tango Therapeutics, Inc. (TNGX)
21.62
+0.54
(+2.56%)
USD |
NASDAQ |
May 21, 16:00
21.60
-0.02
(-0.09%)
After-Hours: 19:59
Tango Therapeutics Research and Development Expense (TTM) : 127.14M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 1.117B |
| Kodiak Sciences, Inc. | 187.28M |
| Recursion Pharmaceuticals, Inc. | 382.53M |
| Hims & Hers Health, Inc. | 166.32M |
| Erasca, Inc. | 94.15M |